- Home
- XERS vs AXGN Comparison
XERS vs AXGN Comparison
Compare XERS & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XERS
- AXGN
- Stock Information
- Founded
- XERS 2005
- AXGN N/A
- Country
- XERS United States
- AXGN United States
- Employees
- XERS N/A
- AXGN N/A
- Industry
- XERS Biotechnology: Pharmaceutical Preparations
- AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- XERS Health Care
- AXGN Health Care
- Exchange
- XERS Nasdaq
- AXGN Nasdaq
- Market Cap
- XERS 1.3B
- AXGN 1.1B
- IPO Year
- XERS 2018
- AXGN N/A
- Fundamental
- Price
- XERS $7.64
- AXGN $23.95
- Analyst Decision
- XERS Strong Buy
- AXGN Strong Buy
- Analyst Count
- XERS 7
- AXGN 7
- Target Price
- XERS $9.43
- AXGN $27.71
- AVG Volume (30 Days)
- XERS 3.0M
- AXGN 898.9K
- Earning Date
- XERS 11-06-2025
- AXGN 10-29-2025
- Dividend Yield
- XERS N/A
- AXGN N/A
- EPS Growth
- XERS N/A
- AXGN N/A
- EPS
- XERS N/A
- AXGN N/A
- Revenue
- XERS $266,137,000.00
- AXGN $214,709,000.00
- Revenue This Year
- XERS $43.89
- AXGN $21.57
- Revenue Next Year
- XERS $20.40
- AXGN $15.79
- P/E Ratio
- XERS N/A
- AXGN N/A
- Revenue Growth
- XERS 42.05
- AXGN 18.72
- 52 Week Low
- XERS $2.82
- AXGN $9.22
- 52 Week High
- XERS $10.08
- AXGN $24.25
- Technical
- Relative Strength Index (RSI)
- XERS 36.31
- AXGN 76.53
- Support Level
- XERS $7.00
- AXGN $23.19
- Resistance Level
- XERS $10.08
- AXGN $24.17
- Average True Range (ATR)
- XERS 0.53
- AXGN 1.14
- MACD
- XERS -0.26
- AXGN 0.43
- Stochastic Oscillator
- XERS 23.38
- AXGN 97.66
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About AXGN Axogen Inc.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.